Tag Archives: NAMI

TeenScreen—Controversial Mental Health Screening Program Closes Down

A “model” program that was part of a controversial plan to screen all US citizens for mental illness has announced that it is closing down.

On 15 November, TeenScreen, a program to detect depression in young people, announced on its website: “The National Center will be winding down its program at the end of this year.”

CCHR exposes list of psycho-pharma front groups

A highly effective public relations technique is the “third party technique” of creating front groups to endorse or promote the need of any service or product. The first party is the original group or client that would benefit more from increased public trust or affinity. The second group is the public or consumers. A third group is created with a contrived name to appear publicly as a disinterested party endorsing the industry of the first party.

Often, the third party, or front group, uses a name that implies authority or concern for the public’s welfare or concerns. You can be sure these bogus front groups are usually only concerned about their clients welfare and themselves.

Harvard Expert Ties Mental Illness “Epidemic” to Big Pharma’s Agenda

For any mental illness or passing mood swing that may trouble a person, the Diagnostic and Statistical Manual of Mental Disorders — better known as the DSM — has a label and a code. Recurring bad dreams? That may be a Nightmare Disorder, or 307.47. Narcolepsy uses the same digits in a different order: 347.00. Fancy feather ticklers? That sounds like Fetishism, or 302.81. Then there’s the ultimate catch-all for vague sadness or uneasiness, General Anxiety Disorder, or 300.02. That’s a label almost everyone can lay claim to.Drug companies are particularly eager to win over faculty psychiatrists at prestigious academic medical centers. Called “key opinion leaders” (KOLs) by the industry, these are the people who through their writing and teaching influence how mental illness will be diagnosed and treated. They also publish much of the clinical research on drugs and, most importantly, largely determine the content of the DSM. In a sense, they are the best sales force the industry could have, and are worth every cent spent on them. Of the 170 contributors to the current version of the DSM (the DSM-IV-TR), almost all of whom would be described as KOLs, ninety-five had financial ties to drug companies, including all of the contributors to the sections on mood disorders and schizophrenia.

The Illusions of Psychiatry

Not only did the DSM become the bible of psychiatry, but like the real Bible, it depended a lot on something akin to revelation. There are no citations of scientific studies to support its decisions. That is an astonishing omission, because in all medical publications, whether journal articles or textbooks, statements of fact are supposed to be supported by citations of published scientific studies. (There are four separate “sourcebooks” for the current edition of the DSM that present the rationale for some decisions, along with references, but that is not the same thing as specific references.) It may be of much interest for a group of experts to get together and offer their opinions, but unless these opinions can be buttressed by evidence, they do not warrant the extraordinary deference shown to the DSM. The DSM-III was supplanted by the DSM-III-R in 1987, the DSM-IV in 1994, and the current version, the DSM-IV-TR (text revised) in 2000, which contains 365 diagnoses. “With each subsequent edition,” writes Daniel Carlat in his absorbing book, “the number of diagnostic categories multiplied, and the books became larger and more expensive. Each became a best seller for the APA, and DSM is now one of the major sources of income for the organization.” The DSM-IV sold over a million copies.

Why Mental Health “Advocacy” Groups Aren’t Calling for Psychiatric Drug Investigation in Arizona Shooting: They’re Pharma Funded

In the wake of the Jared Loughner shooting in Arizona, we pointed out that the press seemed more interested in featuring Pharma-funded mouthpieces speculating on why Loughner wasn’t “treated” (drugged) and using this tragedy to start banging the drum for more government funding for more mental health treatment, (drugs) before even bothering to find out whether or not Loughner was, or had been, on psychiatric drugs. The logical question for anyone concerned with mental health would be; Was Loughner yet another in the long list of mass shooters already under the influence of psychiatric drugs documented to cause mania, psychosis, violence, homicidal and suicidal ideation that have resulted in 54 dead and 105 wounded in 10 such similar massacres? Isn’t that something we should know before spending billions more dollars on a pharmaceutically based mental health agenda? Shouldn’t we be investigating that instead of using this tragedy to get more funding for mental health “treatment”? So let’s just cut to the chase. The most prominent “mental health” groups using this shooting to cry out “give us billions more funding,” are themselves, funded by Pharma. Perhaps that answers the question of why despite the overwhelming evidence psychiatric drugs cause violence and even homicide, groups such as the National Alliance for Mental Illness (NAMI), which claims to be a “patient’s rights” organization for the “mentally ill”, are not calling for an investigation of what, if any role, psychiatric drugs played in this or any other mass shooting in the last 10 years, we are.